Gå direkte til innhold
 

Prosjektarkiv

 
14treff
PeriodeProsjekttittelProsjektleder
2013 - 2016

Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-based vaccine

Meningococcal vaccines for Africa: Impact of MenAfriVac on serogroup A transmission and clinical evaluation of a new protein-bas
Dominique A. Caugant
2010 - 2014

IgA antibodies in saliva as a noninvasive readout for intestinal immune responses

IgA antibodies in saliva as a noninvasive readout for intestinal immune responses
Per Brandtzæg
2010 - 2012

Additional activities related to an ongoing project: Impact of the new vaccine MenAfriVac on carriage of serogroup A Neisseria meningitidis

Additional activities related to an ongoing project: Impact of the new vaccine MenAfriVac on carriage of serogroup A Neisseria m
Dominique A. Caugant
2008 - 2008

Safety and Immunogenicity of Three Doses of ORV 116E Concomitantly Administered with Routine Childhood Vaccines OPV, DPT, Hib and Hep B

Safety and Immunogenicity of Three Doses of ORV 116E Concomitantly Administered with Routine Childhood Vaccines OPV, DPT, Hib an
Tor Arne Strand
2007 - 2007

Severe Streptococcus pyogenes infections in Norway - Molecular genetic analysis of antibiotic resistance and virulence determinants

Severe Streptococcus pyogenes infections in Norway - Molecular genetic analysis of antibiotic resistance and virulence determina
Dominique A. Caugant
2003 - 2003

Utvikling av partikler med internkontroll for økt kvalitetssikring av genteknologi-baserte analyser

Utvikling av partikler med internkontroll for økt kvalitetssikring av genteknologi-baserte analyser
Einar Sverre Berg
2002 - 2003

Vaccine development against tuberculosis. New strategies for prevention of tuberculosis.

Vaccine development against tuberculosis. New strategies for prevention of tuberculosis.
Fredrik Oftung
2002 - 2002

Thirteen international pathogenic neisseria conference, IPNC 2002

Thirteen international pathogenic neisseria conference, IPNC 2002
Dominique A. Caugant
2002 - 2002

Bruk av MucoSafe til påvisning av HIV-infeksjon i store befolkningsgrupper.

Bruk av MucoSafe til påvisning av HIV-infeksjon i store befolkningsgrupper.
Carol Holm-Hansen
2002 - 2003

Utvikling av partikler med internkontroll for økt kvalitetssikring av genteknologi-baserte analyser

Utvikling av partikler med internkontroll for økt kvalitetssikring av genteknologi-baserte analyser
Einar Sverre Berg
2001 - 2002

Ny vaksine mot gruppe A meningokokksykdom til bruk i Afrika.

Ny vaksine mot gruppe A meningokokksykdom til bruk i Afrika.
Einar Rosenqvist
2001 - 2007

Antibiotic resistance and molecular epidemiology of Streptococcus pneumoniae in Norway

Antibiotic resistance and molecular epidemiology of Streptococcus pneumoniae in Norway
Dominique A. Caugant
2000 - 2003

Humanpatogene virus i drikkevann

Humanpatogene virus i drikkevann
Bjørn Grinde
2000 - 2002

Day-care Environment and children's health. Phase II: Controlled intervention study of low ventilation

Day-care Environment and children's health. Phase II: Controlled intervention study of low ventilation
Jouni J. K. Jaakkola